Search Results

Will Arnold

I am a Director in our Healthcare team and have spent my entire career working in Healthcare and Life Sciences M&A, advising private equity clients, and publicly traded and privately owned companies on a broad range of domestic and cross-border transactions.

Clearwater UK advises Lakehouse plc on sale of construction and property services assets

Clearwater advises Investcorp on the acquisition of a majority stake in SEC Newgate through a capital increase of c.€90m

Clearwater advises ICT Project Management Limited on its sale to ActionPoint Group

Tomas Almgren

As part of the team that founded the Swedish operations more than eight years ago, I have, together with the other team members of Clearwater International, built the most successful M&A business in Sweden. Our success is built on the ability to think outside the box combined with hard work and always putting the client’s needs first.

Today I am Managing Partner at Clearwater International and advise Swedish and international clients on a variety of M&A transactions, primarily focused on sell-side mandates for both industrial and private equity clients.

My core strength has always been finding the best innovation solutions for complex transactions and meeting specific client needs.

Some key deals include advising the founder on the divestment of IsaDora to Axcel; advising Latour on its sale of Specma Group to Schouw; advising on the sale of Diamorph to Epiris; advising Transdev Group on its sale of Flygbussarna (Airport coaches); and advising Accent Equity on its sale of Stål & Hyr Group.

James Malcharek

I am a Director in the Industrials & Chemicals team, with a particular responsibility for the Industrial Technology and Building Materials sectors. I joined Clearwater in 2021 from Lazard, where I spent four years, primarily focused on the industrial sector. Before joining Lazard, I qualified as a Chartered Accountant in corporate finance at Ernst & Young. My experience spans public and private companies, primarily advising on mergers, acquisitions, and disposals.

Hemavli Bali

I joined Clearwater in December 2018 to lead M&A advisory within healthcare and life sciences technology and specialist services - including life science commercialisation services, e-clinical solutions, healthcare IT, software and IP driven consultancies. My 21 year career has traversed investment banks, Big Four firms and M&A boutiques and I joined Clearwater for its truly international team, passion for high quality client service, culture and dynamism. I have spent 16 years in M&A advisory, in the UK and the US, and advised on over 40 transactions across the sell- side, buy-side, owner-managed businesses, large corporates, private equity and public to private transactions. I have also provided extensive Board level advice both pre- and post-deal processes. The healthcare and life science industry, and its increasing technology enablement, has been my main focus throughout. Deals I have advised on include the sales of Age UK’s telecare business to Axa PPP Healthcare, Medaxial to Covance, Abacus International to Decision Resources Group and Synergy to DDB, Omnicom. I have previously held roles at Deloitte, Results International, Nomura, Royal Bank of Canada and Ernst & Young. I am a Chartered Accountant and hold a BSc in Economics from the London School of Economics.

Clearwater advises Kettler on sale of its bicycle division to ZEG

Clearwater UK advises UK-listed Lakehouse plc on its cross-border sale of Orchard Energy to World Fuel Services Europe, Ltd, a subsidiary of US-listed World Fuel Services Corporation

Clearwater advises Kerdonis on the sale of its healthcare division to Univi